Fundz
New|Fundz now works inside Claude2 min

Timing. Relevance. Relationships.

Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.

Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.

Trusted by

OracleSnowflakeCloudflareLinkedInGoogleSalesforce
4.8/5 on G2· Since 2015

City Therapeutics prices IPO at $18/share, raising $200M for RNAi therapeutics development.

PUBLIC · CTYOct 16, 2026

Amount Raised

$200 Million

Round Type

IPO

CambridgeBiotechnologyHealth CareTherapeutics

Investors

Oppenheimer & Co. Inc.StifelJefferiesGoldman Sachs & Co. LLC

Description

City Therapeutics priced its initial public offering at $18.00 per share, raising approximately $200 million in gross proceeds from 11.1 million shares. The clinical-stage biotechnology company, which develops next-generation RNA interference therapeutics, began trading on NASDAQ under ticker CTY on October 16, 2026. Goldman Sachs, Jefferies, Stifel, and Oppenheimer served as joint book-running managers. The offering includes a 30-day underwriter option to purchase an additional 1.67 million shares at the same price.

Company Information

Company

City Therapeutics

Location

Cambridge, Massachusetts, United States

About

City Therapeutics is a biopharmaceutical company harnessing next-generation engineering of RNAi trigger molecules to improve and expand the reach of RNAi-based medicines. The company is building a pipeline of innovative RNAi therapeutics to make a significant impact for patients across multiple therapeutic areas. Co-founded by pioneering executives and scientists in RNAi, City Therapeutics is based in Cambridge, MA, and has raised $135 million from leading life sciences investors.

Fundz sees it the moment City Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for City Therapeutics's next move

See what Strategic adds

City Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.